ELIXIR Switzerland
ELIXIR is a Swiss luxury longevity maison offering premium NMN supplementation, with a vision to integrate wearable technology and personalised longevity protocols for individuals seeking to optimise their long-term health and wellbeing.
At a glance
- What it offers
- Dietary Supplement
- Primary health focus
- Midlife and Healthy Ageing
- Company stage
- Early Commercial
About
ELIXIR Switzerland is a Swiss longevity brand focused on NMN (nicotinamide mononucleotide) supplements. Its flagship product contains 300 mg of UTHEVER® Prime NMN per capsule and comes in bottles of 60 capsules. The brand emphasises Swiss formulation, independent laboratory testing and the absence of fillers or additives. Positioned around healthy ageing, beauty and vitality, ELIXIR combines premium branding with educational content on longevity research. Its website shares scientific references and articles exploring NMN, NAD⁺ and emerging approaches to lifelong wellbeing.
Need addressed
Longevity remains a fragmented landscape, where scientific advances, personal health data and everyday wellbeing are rarely brought together in a coherent experience. ELIXIR's vision is to bridge this gap through a considered approach to healthy ageing, combining scientific rigour, personalisation and the art of living well.
Women’s health focus
Primary health area
Midlife and Healthy AgeingELIXIR brings groundbreaking longevity science into a daily supplement designed around one of the body's most fundamental molecules: NAD⁺. NAD⁺ is essential to cellular energy production and plays a vital role in DNA repair, cellular maintenance and numerous biological processes. ELIXIR NMN contains Nicotinamide Mononucleotide (NMN), a direct precursor to NAD⁺, whose levels naturally decline with age. Human clinical studies have demonstrated that NMN supplementation can increase NAD⁺ levels in the blood, supporting its contribution to healthy ageing. This science is particularly relevant to understanding cellular health throughout adulthood and beyond.